Oncotarget · 2016 · 36 citations · 32 references
MedicineMolecular GeneticsOncologyGenomicsMolecular OncologyNeoplasiaCancer GenomicsCervical CancerEndocrine Tumor GeneticsMolecular Tumor ProfilingNeuroendocrine TumorsOncogene MutationsExome SequencingMutationNext-generation Sequencing AnalysisSomatic MutationsTumor Exome SequencingTumor Mutation AnalysisWhole Exome Sequencing StudiesWhole-exome Sequencing Analysis
// Soo Young Cho 1, * , Minhye Choi 2, * , Hyo-Jeong Ban 3, 4, * , Chang Hyeon Lee 5 , Soojun Park 6 , HanKyeom Kim 2 , Young-Sik Kim 2 , Young Seek Lee 3 , Ji-Yun Lee 2 1 Laboratory of Developmental Biology and Genomics, College of Veterinary Medicine, Research Institute for Veterinary Science BK21, Program for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea 2 Department of Pathology, College of Medicine, Korea University, Seoul 02841, Republic of Korea 3 Division of Molecular and Life Sciences, Hanyang University, Ansan 15588, Republic of Korea 4 Division of Bio-Medical Informatics, Center for Genome Science, National Research Institute of Health, Centers for Disease Control and Prevention, Choongchung-Buk-do 28159, Republic of Korea 5 Life Science Solutions Group, Thermo Fisher Scientific Corporation, Seoul 06349, Republic of Korea 6 Bio-Medical IT Research Department, ETRI, Yusoeng-gu, Daejeon 34129, Republic of Korea * These authors have contributed equally to this work Correspondence to: Young Seek Lee, email: yslee@hanyang.ac.kr Ji-Yun Lee, email: jiyun-lee@korea.ac.kr Keywords: cervical small cell neuroendocrine tumor, ATRX, ERBB4, AKT/mTOR, whole exome sequencing Received: July 18, 2016 Accepted: November 22, 2016 Published: December 22, 2016 ABSTRACT Cervical small cell neuroendocrine tumors (CSCNETs) are rare, aggressive neuroendocrine tumors (NETs). Reliable diagnostic and prognostic CSCNET markers are lacking, making diagnosis and prognosis prediction difficult, and treatment strategies limited. Here we provide mutation profiles for five tumor-normal paired CSCNETs using whole exome sequencing (WES). We expanded our assessment of frequently mutated genes to include publicly available data from 55 small intestine neuroendocrine tumors, 10 pancreatic neuroendocrine tumors, 42 small cell lung cancers, six NET cell lines, and 188 cervical cancers, along with our five CSCNETs. We identified 1,968 somatic mutations, including 1,710 missense, 106 nonsense, 144 splice site, 4 lncRNA, 3 nonstop, and 1 start codon mutation. We assigned functions to the 114 most frequently mutated genes based on gene ontology. ATRX , ERBB4 , and genes in the Akt/mTOR pathway were most frequently mutated. Positive cytoplasmic ERBB4 immunohistochemical staining was detected in all CSCNET tumors tested, but not in adjacent normal tissues. To our knowledge, this study is the first to utilize WES in matched CSCNET and normal tissues to identify somatic mutations. Further studies will improve our understanding of how ATRX and ERBB4 mutations and AKT/mTOR signaling promote CSCNET tumorigenesis, and may be leveraged in novel anti-cancer treatment strategies.
32
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex
Dos D. Sarbassov, David A. Guertin, Siraj M. Ali et al. · Science · 2005 · 6.2K citations
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth, Michael D. McLellan, Fabio Vandin et al. · Nature · 2013 · 4.5K citations · Full text
Patterns of somatic mutation in human cancer genomes
Christopher Greenman, Philip Stephens, Raffaella Smith et al. · Nature · 2007 · 3.1K citations · Full text
Life Sciences, Genetics, Oncology +14